Cargando…
Tumor microenvironment: becoming sick of Myc
Several years ago, we described Myc as “the oncogene from hell”, since evidence had just emerged that Myc, aside from being responsible for cell-cycle progression and tumor expansion, was also able to induce genomic instability in culture, wreaking havoc in tumor cells and accelerating tumor progres...
Autores principales: | Whitfield, Jonathan R., Soucek, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SP Birkhäuser Verlag Basel
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285755/ https://www.ncbi.nlm.nih.gov/pubmed/22033838 http://dx.doi.org/10.1007/s00018-011-0860-x |
Ejemplares similares
-
The long journey to bring a Myc inhibitor to the clinic
por: Whitfield, Jonathan R., et al.
Publicado: (2021) -
Strategies to Inhibit Myc and Their Clinical Applicability
por: Whitfield, Jonathan R., et al.
Publicado: (2017) -
MYC inhibitors in multiple myeloma
por: Martínez-Martín, Sandra, et al.
Publicado: (2021) -
Blocking Myc to Treat Cancer: Reflecting on Two Decades of Omomyc
por: Massó-Vallés, Daniel, et al.
Publicado: (2020) -
Structural and Biophysical Insights into the Function of the Intrinsically Disordered Myc Oncoprotein
por: Beaulieu, Marie-Eve, et al.
Publicado: (2020)